BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 28448542)

  • 1. Diminished plasma levels of common γ-chain cytokines in pulmonary tuberculosis and reversal following treatment.
    Kumar NP; Banurekha VV; Nair D; Babu S
    PLoS One; 2017; 12(4):e0176495. PubMed ID: 28448542
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heightened systemic levels of anti-inflammatory cytokines in pulmonary tuberculosis and alterations following anti-tuberculosis treatment.
    Moideen K; Kumar NP; Bethunaickan R; Banurekha VV; Nair D; Babu S
    Cytokine; 2020 Mar; 127():154929. PubMed ID: 31811994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Type 2 diabetes - Tuberculosis co-morbidity is associated with diminished circulating levels of IL-20 subfamily of cytokines.
    Kumar NP; Banurekha VV; Nair D; Kumaran P; Dolla CK; Babu S
    Tuberculosis (Edinb); 2015 Dec; 95(6):707-712. PubMed ID: 26354610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered circulating levels of B cell growth factors and their modulation upon anti-tuberculosis treatment in pulmonary tuberculosis and tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Banurekha VV; Nair D; Sridhar R; Baskaran D; Babu S
    PLoS One; 2018; 13(11):e0207404. PubMed ID: 30427928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased frequencies of circulating CD4⁺ T follicular helper cells associated with diminished plasma IL-21 in active pulmonary tuberculosis.
    Kumar NP; Sridhar R; Hanna LE; Banurekha VV; Nutman TB; Babu S
    PLoS One; 2014; 9(10):e111098. PubMed ID: 25343703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of Th1/Tc1 and Th17/Tc17 responses in pulmonary tuberculosis by IL-20 subfamily of cytokines.
    Kumar NP; Moideen K; Banurekha VV; Nair D; Babu S
    Cytokine; 2018 Aug; 108():190-196. PubMed ID: 29684756
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating Angiogenic Factors as Biomarkers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
    Kumar NP; Banurekha VV; Nair D; Babu S
    PLoS One; 2016; 11(1):e0146318. PubMed ID: 26727122
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rv2204c, Rv0753c and Rv0009 antigens specific T cell responses in latent and active TB - a flow cytometry-based analysis.
    Pathakumari B; Devasundaram S; Maddineni P; Raja A
    Int J Med Microbiol; 2018 Mar; 308(2):297-305. PubMed ID: 29325881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heightened Systemic Levels of Neutrophil and Eosinophil Granular Proteins in Pulmonary Tuberculosis and Reversal following Treatment.
    Moideen K; Kumar NP; Nair D; Banurekha VV; Bethunaickan R; Babu S
    Infect Immun; 2018 Jun; 86(6):. PubMed ID: 29632246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity.
    Hasan Z; Jamil B; Khan J; Ali R; Khan MA; Nasir N; Yusuf MS; Jamil S; Irfan M; Hussain R
    Scand J Immunol; 2009 Mar; 69(3):259-67. PubMed ID: 19281538
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma chemokines are biomarkers of disease severity, higher bacterial burden and delayed sputum culture conversion in pulmonary tuberculosis.
    Kumar NP; Moideen K; Nancy A; Viswanathan V; Shruthi BS; Sivakumar S; Natarajan M; Kornfeld H; Babu S
    Sci Rep; 2019 Dec; 9(1):18217. PubMed ID: 31796883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heightened circulating levels of antimicrobial peptides in tuberculosis-Diabetes co-morbidity and reversal upon treatment.
    Kumar NP; Moideen K; Viswanathan V; Sivakumar S; Menon PA; Kornfeld H; Babu S
    PLoS One; 2017; 12(9):e0184753. PubMed ID: 28910369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in inflammatory protein and lipid mediator profiles persist after antitubercular treatment of pulmonary and extrapulmonary tuberculosis: A prospective cohort study.
    Vinhaes CL; Oliveira-de-Souza D; Silveira-Mattos PS; Nogueira B; Shi R; Wei W; Yuan X; Zhang G; Cai Y; Barry CE; Via LE; Fukutani KF; Andrade BB; Mayer-Barber KD
    Cytokine; 2019 Nov; 123():154759. PubMed ID: 31226436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered plasma levels of βC and γC chain cytokines and post-treatment modulation in tuberculous lymphadenitis.
    Kathamuthu GR; Moideen K; Sridhar R; Baskaran D; Babu S
    Cytokine; 2021 Feb; 138():155405. PubMed ID: 33341600
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Profiling leucocyte subsets in tuberculosis-diabetes co-morbidity.
    Kumar NP; Moideen K; Dhakshinraj SD; Banurekha VV; Nair D; Dolla C; Kumaran P; Babu S
    Immunology; 2015 Oct; 146(2):243-50. PubMed ID: 26095067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coincident pre-diabetes is associated with dysregulated cytokine responses in pulmonary tuberculosis.
    Kumar NP; Banurekha VV; Nair D; Sridhar R; Kornfeld H; Nutman TB; Babu S
    PLoS One; 2014; 9(11):e112108. PubMed ID: 25393696
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-10 dependent suppression of type 1, type 2 and type 17 cytokines in active pulmonary tuberculosis.
    Kumar NP; Gopinath V; Sridhar R; Hanna LE; Banurekha VV; Jawahar MS; Nutman TB; Babu S
    PLoS One; 2013; 8(3):e59572. PubMed ID: 23544075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The expressions and roles of different forms of IL-22 in Mycobacterium tuberculosis infection.
    Liu Y; Ou Q; Liu Q; Gao Y; Wu J; Zhang B; Weng X; Shao L; Zhang W
    Tuberculosis (Edinb); 2017 Dec; 107():95-103. PubMed ID: 29050778
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma Proinflammatory Cytokines Are Markers of Disease Severity and Bacterial Burden in Pulmonary Tuberculosis.
    Kumar NP; Moideen K; Banurekha VV; Nair D; Babu S
    Open Forum Infect Dis; 2019 Jul; 6(7):ofz257. PubMed ID: 31281858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Coexistent Malnutrition Is Associated with Perturbations in Systemic and Antigen-Specific Cytokine Responses in Latent Tuberculosis Infection.
    Anuradha R; Munisankar S; Bhootra Y; Kumar NP; Dolla C; Kumaran P; Babu S
    Clin Vaccine Immunol; 2016 Apr; 23(4):339-45. PubMed ID: 26865593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.